Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α cardiac myosin heavy chain gene

Journal of Clinical Investigation

Volumn 103, Issue 1, 1999, Pages 147-153

  Fatkin, Diane ^a   Christe, Michael E ^b   Aristizabal, Orlando ^c   McConnell, Bradley K ^b   Srinivasan, Shardha ^c   Schoen, Frederick J ^a   Seidman, Christine E ^a   Turnbull, Daniel H ^c   Seidman, J G ^b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; MUSCLE PROTEIN; MYOSIN HEAVY CHAIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL VIABILITY; GENE; GENE MUTATION; HISTOPATHOLOGY; MISSENSE MUTATION; MOUSE; NEWBORN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0032943836     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4631     Document Type: Article

References (42)

1. Seidman, C., and Seidman, J.G. 1995. Gene mutations that cause familial hypertrophic cardiomyopathy. In Molecular cardiovascular medicine. E. Haber, editor. Scientific American. New York, NY. 193-210.
2. Watkins, H., Seidman, J.G., and Seidman, C.E. 1995. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum. Mol. Genet 4:1721-1727.
3. Geisterfer-Lowrance, A.A.T., et al. 1996. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:731-734.
4. Watkins, H., et al. 1992. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 326:1108-1114.
5. Srinivasan, S., et al. 1998. Noinnvasive, in utero imaging of mouse embryonic heart development using 40 MHz echocardiography. Circulation. 98:912-918.
6. Anstizabal, O., Christopher, D.A., Foster, F.S., and Turnbull, D.H. 40 MHz echocardiography scanner for cardiovascular assessment of mouse embryos. Ultrasound Med. Biol. In press.
7. Lockwood, G.R., Ryan, L.K., Hunt, J.W., and Foster, F.S. 1991. Measurement of the ultrasonic properties of vascular tissues and blood from 35 to 65 MHz. Ultrasound Med. Biol. 17:656-666.
8. McConnell, B.K., Moravec, C.S., and Bond, M. 1998. Troponin-I phosphorylation and myofilament calcium sensitivity during decompensared cardiac failure. Am. J. Physiol. 274:H385-H396.
9. Bland, J.M., and Altman, D.G. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:307-310.
10. Lyons, G.E., Schiaffino, S., Sassoon, D., Barton, P., and Buckingham, M. 1990. Developmental regulation of myosin gene expression in mouse cardiac muscle. J. Cell Biol. 111:2427-2436.
11. Schwartz, K., et al. 1981. Myosin isoenzyme distribution correlates with speed of myocardial contraction. J. Mol. Cell. Cardiol. 13:1071-1075.
12. Dorn, G.W., Robbins, J., Ball, N., and Walsh, R.A. 1994. Myosin heavy chain regulation and myocyte contractile depression afer LV hypertrophy in aortic-banded mice. Am J. Physiol. 267:H400-H405.
13. Barany, M. 1967. ATPase activity of myosin correlated with speed of muscle shortening. J. Gen. Physiol. 50(Suppl.):197-218.
14. Pope, B., Hoh, J.F.Y., and Weeds, A. 1980. The ATPase activities of rat cardiac myosin isoenzymes. FEBS Lett. 118:205-208.
15. Lompre, A.M., et al. 1981. Species- and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Dev. Biol. 84:286-290.
16. Pagani, E.D., and Julian, F.J. 1984. Rabbit papillary muscle myosin isoenzymes and the velocity of muscle shortening. Circ. Res. 54:586-594.
17. Gutgesell, H.P., Paquet, M., Duff, D.F., and McNamara, D.G. 1977. Evaluation of left ventricular size and function by echocardiography. Circulation. 56:457-462.
18. Henry, W.L., Gardin, J.M, and Ware, J.H. 1980. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 62:1054-1061.
19. St. John Sutton, M.G., Marier, D.L., Oldershaw, P.J., Sacchetti, R., and Gibson, D.G. 1982. Effect of age related changes in chamber size, wall thickness and heart rate on left ventricular function in normal children. Br Heart J. 48:342-351.
20. Magid, N.M., et al. 1988. Hypertrophic and functional response to experimental chronic aortic regurgitation. J. Mol. Cell. Cardiol. 20:239-246.
21. Hoit, B.D., Khoury, S.F., Kranias, E.G., Ball, N., and Walsh, R.A. 1995. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ. Res. 77:633-637.
22. Pollick, C., Hale, S.L., and Kloner, R.A. 1995. Echocardiographic and cardiac Doppler assessment of mice. J. Am. Soc. Echocardiogr. 8:602-610.
23. Tanaka, N., et al. 1996. Transrhoracic echocardiography in models of cardiac disease in the mouse. Circulation. 94:1109-1117.
24. Pawlush, D.G., Moore, R.L., Musch, T.I., and Davidson, W.R. 1993. Echocardiographic evaluation of size, function and mass of normal and hypertrophied rat ventricles. J. Appl. Physiol. 74:2598-2605.
25. Raymnent, I., et al. 1993. Structure of the actin-myosin complex and its implications for muscle contraction. Science. 261:58-65.
26. Sweeney, H.L., Straceski, A.J., Leinwand, L.A., Tikunov, B.A., and Faust, L. 1994. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J. Biol. Chem. 269:1603-1605.
27. Sata, M., and Ikebe, M. 1996. Functional analysis of the mutations in the human cardiac β-myosin that are responsible for familial hypertrophic cardiomyopathy. J. Clin. Invest. 98:2866-2873.
28. Cuda, G., Fananapazir, L., Zhu, W.-S., Sellars, J.R., and Epstein, N.D. 1993. Skeletal muscle expression and abnormal function of b-myosin in hypertrophic cardiomyopathy. J. Clin. Invest. 91:2861-2865.
29. Lankford, E.B., Epstein, N.D., Fananapazir, L., and Sweeney, H.L. 1995. Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Infest. 95:1409-1414.
30. 403/+ mouse model of familial hypertrophiC cardiomyopathy. J. Clin. Invest. 101:1775-1783.
31. Gwathmey, J.K., et aL. 1991. Diastolic dysfunction in hypertrophic cardiomyopathy. J. Clin. Invest. 87:1023-1031.
32. Anderson, H.C. 1983. Calcific diseases. Arch. Pathol. Lab. Med. 107:341-347.
33. Levy, R.J., et al. 1983. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am. J. Pathol. 113:143-155.
34. Topaz, O. 1991. Myocardial calcifications in neonates and infants: a unique tissue reaction. South. Med. J. 84:891-895.
35. Parodi, O., et al. 1993. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation. 88:509-522.
36. Nishi, H., et al. 1994. Possible gene dosage effect of a mutant cardiac β-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 200:549-556.
37. Anversa, P., et al. 1995. Ischemic cardiomyopathy: myocyte cell loss, myocyte cellular hypertrophy and myocyte cellular hyperplasia. Ann. NY Acad. Sci., 752:47-64.
38. Anversa, P., Zhang, X., Li, P., and Capasso, J.M. 1992. Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats. J. Clin. Invest. 89:618-629.
39. Anversa, P., T. Palackal, E.H. Sonnenblick, G. Olivetti, and J.M. Capasso. 1990. Hypertensive cardiomyopathy. J. Clin. Invest. 85:994-997.
40. Spinale, F.G., Zellner, J.L., Tomita, M., Crawford, F.A., and Zile, M.R. 1991. Relation between ventricular and myocyte remodeling with the development and regression of supra ventricular tachycardia-induced cardiomyopathy. Circ Res. 69:1058-1067.
41. Kajsturam, J., et al. 1995. The cellular basis of pacing-induced dilated cardiomyopathy. Circulation. 92:2306-2317.
42. Olivetti G., Melissari, M., Capasso, J.M., and Anversa, P. 1991. Cardiomyopathy of the aging human heart. Circ. Res. 68:1560-1568.